|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Provision charge (benefit) for credit losses | |||||
| Provision charge for credit losses on loans and securities | |||||
| Provision (benefit) charge for credit losses on off-balance sheet credit exposures | |||||
| Deferred tax expense (benefit) | |||||
| Amortization of operating lease right-of-use assets | |||||
| Income on Bank-owned life insurance | |||||
| Net amortization of premiums and discounts on securities | |||||
| Accretion of net deferred loan fees | |||||
| Amortization of premiums on purchased loans, net | |||||
| Originations of loans held for sale | |||||
| Loans transferred to held for sale | |||||
| Proceeds from sales of loans held for sale | |||||
| ESOP expense | |||||
| Allocation of stock award shares | |||||
| Allocation of stock options | |||||
| Net gain on sale of loans | |||||
| Net (gain) loss on securities transactions | |||||
| Net (gain) loss on sale of premises and equipment | |||||
| Net loss (gain) on sale of foreclosed assets | |||||
| Net change in balance sheet: | |||||
| Increase in accrued interest receivable | |||||
| (Increase) decrease in other assets | |||||
| (Decrease) increase in other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Net increase in loans | |||||
| Purchases of loans | |||||
| Proceeds from sales of loans held for investment | |||||
| Proceeds from sales of foreclosed assets | |||||
| Proceeds from maturities, calls and paydowns of investment securities held to maturity | |||||
| Purchases of investment securities held to maturity | |||||
| Proceeds from sales of securities available for sale | |||||
| Proceeds from maturities calls and paydowns of securities available for sale | |||||
| Purchases of available for sale debt securities | |||||
| Proceeds from redemption of Federal Home Loan Bank stock | |||||
| Purchases of Federal Home Loan Bank stock | |||||
| Cash received, net of cash consideration paid for acquisition | |||||
| BOLI claim benefits received | |||||
| Proceeds from sales of premises and equipment | |||||
| Purchases of premises and equipment | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Net increase (decrease) in deposits | |||||
| (Decrease) increase in mortgage escrow deposits | |||||
| Purchase of treasury stock | |||||
| Purchase of employee restricted shares to fund statutory tax withholding | |||||
| Cash dividends paid to stockholders | |||||
| Stock options exercised | |||||
| Proceeds from long-term borrowings | |||||
| Repayments of long-term borrowings | |||||
| Net increase (decrease) in short-term borrowings | |||||
| Repayment of subordinated debentures | |||||
| Proceeds from subordinated debentures | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Restricted cash at beginning of period | |||||
| Total cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Restricted cash at end of period | |||||
| Total cash, cash equivalents and restricted cash at end of period | |||||
| Cash paid during the period for: | |||||
| Interest on deposits and borrowings | |||||
| Income taxes | |||||
| Non cash investing activities: | |||||
| Initial recognition of operating lease right-of-use assets | |||||
| Initial recognition of operating lease liabilities | |||||
| Transfer of loans receivable to foreclosed assets | |||||
| Acquisitions: | |||||
| Non-cash assets acquired at fair value: | |||||
| Investment securities | |||||
| Loans held for sale | |||||
| Loans held for investment | |||||
| Bank-owned life insurance | |||||
| Goodwill and other intangible assets | |||||
| Bank premises and equipment | |||||
| Other assets | |||||
| Total non-cash assets acquired at fair value | |||||
| Liabilities assumed: | |||||
| Deposits | |||||
| Borrowings and subordinated debt | |||||
| Subordinated debentures | |||||
| Other liabilities | |||||
| Total liabilities assumed | |||||
| Common stock issued for acquisitions | |||||
Loading...